123 related articles for article (PubMed ID: 19666638)
1. The relationship between high-frequency right ventricular pacing and paroxysmal atrial fibrillation burden.
Silberbauer J; Veasey RA; Freemantle N; Arya A; Boodhoo L; Sulke N
Europace; 2009 Nov; 11(11):1456-61. PubMed ID: 19666638
[TBL] [Abstract][Full Text] [Related]
2. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular pacing and atrial fibrillation: villain, victim, or just misunderstood?
Sweeney MO
Europace; 2009 Nov; 11(11):1413-4. PubMed ID: 19880404
[No Abstract] [Full Text] [Related]
4. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
Russo V; Rago A; Papa AA; Politano L; Golino P; Russo MG; Calabrò R; Nigro G
Kardiol Pol; 2013; 71(11):1147-53. PubMed ID: 24297712
[TBL] [Abstract][Full Text] [Related]
5. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
[TBL] [Abstract][Full Text] [Related]
6. The risk of atrial fibrillation during right ventricular pacing.
Pastore G; Zanon F; Baracca E; Aggio S; Corbucci G; Boaretto G; Roncon L; Noventa F; Barold SS
Europace; 2016 Mar; 18(3):353-8. PubMed ID: 26443444
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.
Veasey RA; Arya A; Freemantle N; Silberbauer J; Patel NR; Lloyd GW; Sulke AN
J Interv Card Electrophysiol; 2010 Jun; 28(1):51-7. PubMed ID: 20082131
[TBL] [Abstract][Full Text] [Related]
10. Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients.
Schuchert A; Rebeski HP; Peiffer T; Bub E; Dietz A; Mortensen K; Aydin MA; Camm J; Gazarek S; Meinertz T;
Pacing Clin Electrophysiol; 2008 Aug; 31(8):929-34. PubMed ID: 18684247
[TBL] [Abstract][Full Text] [Related]
11. Clinical, echocardiographic, and pacing parameters affecting atrial fibrillation burden in patients with tachycardia-bradycardia syndrome.
Ciszewski JB; Chwyczko T; Kowalik I; Majda W; Farkowski MM; Jankowska A; Borowiec A; Syska P; Szwed H; Pytkowski M
Kardiol Pol; 2018; 76(2):338-346. PubMed ID: 29131294
[TBL] [Abstract][Full Text] [Related]
12. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L;
Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.
Caldwell JC; Contractor H; Petkar S; Ali R; Clarke B; Garratt CJ; Neyses L; Mamas MA
Europace; 2009 Oct; 11(10):1295-300. PubMed ID: 19648586
[TBL] [Abstract][Full Text] [Related]
14. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
[TBL] [Abstract][Full Text] [Related]
15. Newly detected atrial fibrillation following dual chamber pacemaker implantation.
Cheung JW; Keating RJ; Stein KM; Markowitz SM; Iwai S; Shah BK; Lerman BB; Mittal S
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1323-8. PubMed ID: 17081212
[TBL] [Abstract][Full Text] [Related]
16. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation.
Silberbauer J; Veasey RA; Cheek E; Maddekar N; Sulke N
J Interv Card Electrophysiol; 2009 Oct; 26(1):31-40. PubMed ID: 19636688
[TBL] [Abstract][Full Text] [Related]
20. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study.
Wiberg S; Lönnerholm S; Jensen SM; Blomström P; Ringqvist I; Blomström-Lundqvist C
Pacing Clin Electrophysiol; 2003 Sep; 26(9):1841-8. PubMed ID: 12930498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
